OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$19.93

-0.32 (-1.58 %)

(As of 01/25/2021 12:00 AM ET)

Add

Compare

Today's Range

$19.68

Now: $19.93▼

$20.00

50-Day Range

$19.21

MA: $20.92▼

$22.01

52-Week Range

$11.09

Now: $19.93▼

$22.99

Volume30,381 shs

Average Volume27,249 shs

Market Capitalization$27.32 billion

P/E Ratio71.18

Dividend Yield0.35%

Beta0.68

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Imaging Business segment provides digital cameras, IC and voice recorders, mirrorless interchangeable-lens cameras, and interchangeable lenses. The Others segment offers biomedical materials. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and GI- and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.

MarketRank^™

Overall MarketRank^™

1.19 out of 5 stars

Medical Sector

829th out of 1,922 stocks

Structural Clay Products Industry

1st out of 3 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Olympus.

2.4 Community Rank

Outperform Votes
Olympus has received 173 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Olympus has received 190 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Olympus has received 52.34% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Olympus and other stocks. Vote “Outperform” if you believe OCPNY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OCPNY will underperform the S&P 500 over the long term. You may vote once every thirty days.

1.7 Dividend Strength

Dividend Yield
Olympus has a dividend yield of 0.35%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Olympus does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Olympus is 19.44%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Olympus will have a dividend payout ratio of 11.48% next year. This indicates that Olympus will be able to sustain or increase its dividend.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Olympus insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.10% of the stock of Olympus is held by institutions.

1.9 Earnings and Valuation

Earnings Growth
Earnings for Olympus are expected to grow by 281.25% in the coming year, from $0.16 to $0.61 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Olympus is 71.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.51.
Price to Earnings Ratio vs. Sector
The P/E ratio of Olympus is 71.18, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 36.79.
Price to Book Value per Share Ratio
Olympus has a P/B Ratio of 7.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Structural clay products

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:OCPNY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.olympus-global.com

Phone813-3340-2111

Employees35,174

Year FoundedN/A

Debt

Debt-to-Equity Ratio1.02

Current Ratio1.88

Quick Ratio1.35

Price-To-Earnings

Trailing P/E Ratio71.18

Forward P/E Ratio124.56

P/E GrowthN/A

Sales & Book Value

Annual Sales$7.32 billion

Price / Sales3.73

Cash Flow$0.80 per share

Price / Cash Flow24.80

Book Value$2.51 per share

Price / Book7.94

Profitability

EPS (Most Recent Fiscal Year)$0.36

Net Income$475.36 million

Net Margins5.34%

Return on Equity10.82%

Return on Assets3.98%

Miscellaneous

Outstanding Shares1,370,915,000

Market Cap$27.32 billion

Next Earnings Date2/4/2021 (Estimated)

OptionableNot Optionable

$19.93

-0.32 (-1.58 %)

(As of 01/25/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

Olympus (OTCMKTS:OCPNY) Frequently Asked Questions

How has Olympus' stock price been impacted by Coronavirus (COVID-19)?

Olympus' stock was trading at $17.6660 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OCPNY stock has increased by 12.8% and is now trading at $19.93.
View which stocks have been most impacted by COVID-19.

Is Olympus a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Olympus in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" Olympus stock.
View analyst ratings for Olympus or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Olympus?

Wall Street analysts have given Olympus a "Strong Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Olympus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Olympus' next earnings date?

Olympus is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Olympus.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings results on Wednesday, August, 5th. The company reported ($0.02) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The business had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.29 billion. Olympus had a net margin of 5.34% and a trailing twelve-month return on equity of 10.82%.
View Olympus' earnings history.

Is Olympus a good dividend stock?

Olympus pays an annual dividend of $0.07 per share and currently has a dividend yield of 0.35%. The dividend payout ratio of Olympus is 19.44%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Olympus will have a dividend payout ratio of 11.48% next year. This indicates that Olympus will be able to sustain or increase its dividend.
View Olympus' dividend history.

Who are some of Olympus' key competitors?

Some companies that are related to Olympus include AstraZeneca PLC (AZN.L) (AZN), GlaxoSmithKline (GSK), CSL (CSLLY), Stryker (SYK), Intuitive Surgical (ISRG), Gilead Sciences (GILD), Anthem (ANTM), Zoetis (ZTS), Becton, Dickinson and (BDX), GlaxoSmithKline plc (GSK.L) (GSK), Vertex Pharmaceuticals (VRTX), Illumina (ILMN), Bayer Aktiengesellschaft (BAYRY), Regeneron Pharmaceuticals (REGN) and Moderna (MRNA).
View all of OCPNY's competitors.

Who are Olympus' key executives?

Olympus' management team includes the following people:

Hiroyuki Tsuji, Director
Mr. Yasuo Takeuchi, Pres, CEO, Representative Exec. Officer & Director (Age 64)
Mr. Chikashi Takeda, Exec. Officer & CFO (Age 59)
Mr. Nacho Abia, COO & Exec. Officer (Age 53)
Mr. Akihiro Taguchi, CTO & Exec. Officer (Age 63)
Mr. Stefan Kaufmann, Chief Admin. Officer, Exec. Officer & Director (Age 53)
Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel
Ms. Caroline H. West, Chief Compliance Officer (Age 63)
Mr. Mark Miller, Global Chief Communications Officer
Shigeto Ohtsuki, Corp. Officer & HR Head

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $19.93.

How big of a company is Olympus?

Olympus has a market capitalization of $27.32 billion and generates $7.32 billion in revenue each year. The company earns $475.36 million in net income (profit) each year or $0.36 on an earnings per share basis. Olympus employs 35,174 workers across the globe.

What is Olympus' official website?

The official website for Olympus is www.olympus-global.com.

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]

This page was last updated on 1/26/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here